Despite remarkable therapeutic advances, hepatitis C virus (HCV) infection continues to be
a major global problem. While the development of highly effective direct-acting antivirals has …

Background: Direct-acting antiviral (DAA) therapies have simplified HCV treatment, and
publicly funded Canadian drug plans have eliminated disease-stage restrictions for …

Background Moldova, an upper-middle-income country in Eastern Europe, is facing a high
burden of hepatitis C virus (HCV). Our objective was to assist the National Agency of Public …

Abstract Background and Aims In 2015, the country of Georgia launched an elimination
program aiming to reduce the prevalence of Hepatitis C virus (HCV) infection by 90% from …

As part of a multinational study to evaluate the Bioline Hepatitis C virus (HCV) point-of-care
(POC) testing in sub-Saharan Africa (SSA), this narrative review summarises regulatory …

Background Pharmacogenomics (PGx) was one of the rst genomics applications to hold
promise in precision medicine. The cost-effectiveness of PGx has been estimated for many …

Materials and methods. The objects of the study are dry extracts obtained from the lavender
herb with purified water and ethanol solutions (40 and 70%). The main biologically active …

Determination of the socially oriented role of pharmacists in the prevention, diagnosis and
treatment of patients with viral hepatitis | ScienceRise: Pharmaceutical Science Skip to main …

As part of a multinational study to evaluate the Bioline Hepatitis C virus (HCV) point-ofcare
(POC) testing in sub-Saharan Africa (SSA), this narrative review summarises regulatory …

На сьогодні парентеральні ВГ в усьому світі є однією з найбільш значущих медико-
соціальних проблем та становлять глобальну загрозу для здоров'я населення, котрій …